Hasenclever, Dirk

Multiple targeted therapies: is there a place for Vach type-3 or type-4 design trials. [electronic resource] - Biometrical journal. Biometrische Zeitschrift Dec 2006 - 911-3; discussion 914-5 p. digital

Publication Type: Comment; Journal Article

0323-3847

10.1002/bimj.200610298 doi


Antineoplastic Agents--therapeutic use
Biometry--methods
Clinical Trials, Phase III as Topic--methods
Data Interpretation, Statistical
Drug Delivery Systems--methods
Humans
Neoplasms--drug therapy
Patient Selection
Research Design